HIV cure research: advances and prospects.

  title={HIV cure research: advances and prospects.},
  author={Caroline Passaes and Asier S{\'a}ez-Ciri{\'o}n},

Tables from this paper

HIV cure strategies: which ones are appropriate for Africa?

Since most people living with HIV are in Africa, methods being developed for a cure must be amenable to clinical trials and deployment on the continent and comments on their appropriateness for Africa are comments.

Gene therapy for HIV infection

Current gene therapy strategies investigated for HIV infection as well as the latest communications on HIV eradication presented at international conferences are reviewed.

Eradication of HIV-1 latent reservoirs through therapeutic vaccination

The perspective on HIV cure and the new approaches the team is undertaking to eradicate the established pro-viral reservoir are described.

Treatment of Human Immunodeficiency Virus-1: Current Challenges and Future Perspectives

The purpose of this literature review is to discuss the state of the art in HIV‑1 research, with a particular focus on the mechanisms by which HIVâ£1 eradication has thus far remained an unattainable goal.

The research progress of the functional cure of AIDS

This brief review focuses on the achievement in functional cure of AIDS.

Progress toward curing HIV infections with hematopoietic stem cell transplantation.

  • S. SmileyAnjali Singh J. Rice
  • Biology, Medicine
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
  • 2015
A workshop provided a venue for in-depth discussion of whether HSCT could be exploited to cure HIV in cancer patients requiring such procedures and how HSCT might be applied to a broader community of HIV-infected persons in whom the risks of HSCT currently outweigh the likelihood and benefits of HIV cure.

Immune responses during spontaneous control of HIV and AIDS: what is the hope for a cure?

The insights into the immune mechanisms of virus control, the impact of early virus–host interactions and why chronic inflammation, a hallmark of HIV infection, is an obstacle to a cure are described.

Lessons Learned From Failures and Success Stories of HIV Breakthroughs: Are We Getting Closer to an HIV Cure?

There is a continuous search for an HIV cure as the success of ART in blocking HIV replication and the role of CD4+ T cells in HIV pathogenesis and immunity do not entirely eradicate HIV. The Berlin

So Pathogenic or So What?—A Brief Overview of SIV Pathogenesis with an Emphasis on Cure Research

The origins of various SIV strains utilized in cure and comorbidity research as well as their respective animal species used are discussed, with comparisons between pathogenic infections and nonpathogenic infections that occur in natural hosts of SIVs.



Control of HIV despite the discontinuation of antiretroviral therapy.

To the Editor: Eradication of the human immunodeficiency virus (HIV) is a difficult goal to achieve, because a reservoir of replication-competent HIV is established in resting CD4 T lymphocytes soon

Immune reconstitution under antiretroviral therapy: the new challenge in HIV-1 infection.

In this review, the tools at their disposal to identify the various mechanisms at work in a given patient and the specific therapeutic strategies the authors could propose based on this etiologic diagnosis are discussed.

Will it be possible to live without antiretroviral therapy?

A better understanding of the mechanisms underlying control of HIV infection or disease in some patients has already led to successful approaches in certain individuals, but much work is still needed to generalize these results to the global population of HIV-infected patients.

The end of AIDS: HIV infection as a chronic disease

HIV: Shock and kill

The authors report the first in vivo evidence that vorinostat can disrupt proviral latency of HIV-1, and some toxic effects that would need to be considered when assessing the risks and benefits of attempts to eradicate HIV infection using this or similar drugs.

Prevention of HIV-1 infection with early antiretroviral therapy.

The early initiation of antiretroviral therapy reduced rates of sexual transmission of HIV-1 and clinical events, indicating both personal and public health benefits from such therapy.

Reduction of Immune Activation with Chloroquine Therapy during Chronic HIV Infection

The data indicate that treatment with CQ reduces systemic T-cell immune activation and, thus, that its use may be beneficial for certain groups of HIV-infected individuals.

Role of PD-1 in HIV Pathogenesis and as Target for Therapy

A review of recent advances in understanding of the PD-1 pathway in HIV infection, and the lessons learned from studies in the SIV model and cancer are summarized.

Long-term immunovirologic control following antiretroviral therapy interruption in patients treated at the time of primary HIV-1 infection

Five out of 32 patients who received very early and prolonged antiretroviral therapy displayed an unusual, sustained immunovirological control after treatment discontinuation (mean duration: 77

Post-Treatment HIV-1 Controllers with a Long-Term Virological Remission after the Interruption of Early Initiated Antiretroviral Therapy ANRS VISCONTI Study

The results show that early and prolonged cART may allow some individuals with a rather unfavorable background to achieve long-term infection control and may have important implications in the search for a functional HIV cure.